Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers.

European urology - 1 Nov 2014

Gulati Sakshi, Martinez Pierre, Joshi Tejal, Birkbak Nicolai Juul, Santos Claudio R, Rowan Andrew J, Pickering Lisa, Gore Martin, Larkin James, Szallasi Zoltan, Bates Paul A, Swanton Charles, Gerlinger Marco

Abstract excerpt

BACKGROUND: Candidate biomarkers have been identified for clear cell renal cell carcinoma (ccRCC) patients, but most have not been validated. OBJECTIVE: To validate published ccRCC prognostic biomarkers in an independent patient cohort and to assess intratumour heterogeneity (ITH) of the most promising markers to guide biomarker optimisation. DESIGN, SETTING, AND PARTICIPANTS: Cancer-specific survival (CSS) for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Kidney Neoplasms

Share to Multivariate Analysis

Share to Neoplasm Staging

Share to Predictive Value of Tests

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 25047176
DOI: 10.1016/j.eururo.2014.06.053
PMCID: PMC4410302

Genes

EDNRB
TSPAN7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers.PMID 25047176Read ↗

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?Semantic proximity Read ↗

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.Semantic proximity Read ↗

Review of Prognostic Expression Markers for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.Semantic proximity Read ↗

Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.Semantic proximity Read ↗

Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type.Semantic proximity Read ↗

Prognostic value of cross-omics screening for kidney clear cell renal cancer survivalSemantic proximity Read ↗

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.